Aveo Pharmaceuticals Inc (NASDAQ:AVEO)

2.22
Delayed Data
As of May 25
 -0.06 / -2.63%
Today’s Change
0.63
Today|||52-Week Range
4.24
-20.43%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues18.1M19.0M2.5M7.6M
 
 
 
 
 
Depreciation And Amortization6.2M9.6M30.0K0.00
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses50.6M17.5M31.9M34.3M
 
 
 
 
 
Research And Development38.3M12.9M23.7M25.2M
 
 
 
 
 
Total Operating Expenses56.8M27.1M31.9M34.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-38.7M-8.1M-29.4M-26.7M
 
 
 
 
 
Extraordinary Credit--6.4M4.8M0.00
 
 
 
Extraordinary Charge-11.7M-4.4M0.00-35.8M
 
 
 
 
Interest Expense On Debt2.4M2.3M1.9M2.4M
 
 
 
 
 
Other Expenses66.0K-6.7M-195.0K0.00
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-52.7M-15.0M-26.8M-64.9M
 
 
 
 
 
Income Taxes0.000.00-101.0K-101.0K
 
 
 
Net Income-52.7M-15.0M-26.9M-65.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS52.3M55.7M69.3M105.9M
 
 
 
 
 
Shares To Calculate EPS Diluted52.3M55.7M69.3M105.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.01-$0.27-$0.39-$0.61
 
 
 
 
 
EPS Diluted-$1.01-$0.27-$0.39-$0.61